MEITAV INVESTMENT HOUSE LTD - INTEC PHARMA LTD JERUSALEM ownership

Quarter-by-quarter ownership
MEITAV INVESTMENT HOUSE LTD ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q2 2021$840,000
+58.8%
241,982
+100.0%
0.01%
-26.7%
Q1 2021$529,000
+26.9%
120,991
+0.1%
0.02%
-6.2%
Q4 2020$417,000120,8160.02%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q3 2021
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 443,008$1,936,0000.24%
GSA CAPITAL PARTNERS LLP 46,917$205,0000.03%
SABBY MANAGEMENT, LLC 37,501$164,0000.03%
MEITAV INVESTMENT HOUSE LTD 120,991$529,0000.02%
TWO SIGMA SECURITIES, LLC 11,396$50,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 15,089$65,0000.00%
CREDIT SUISSE AG/ 40,875$179,0000.00%
GOLDMAN SACHS GROUP INC 26,658$116,0000.00%
MORGAN STANLEY 1,129$5,0000.00%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders